Shanghai HeartCare Medical Technology Corporation Limited (6609.HK) HKSE

55.15

+0.8(+1.45%)

Updated at October 20 09:37AM

Currency In HKD

Shanghai HeartCare Medical Technology Corporation Limited

Address

Building 38

Shanghai,

China

Phone

N/A

Sector

Healthcare

Industry

Medical - Devices

Employees

344

First IPO Date

August 20, 2021

Key Executives

NameTitlePayYear Born
Mr. Guohui WangChairman & Chief Executive Officer1.79M1979
Ms. Kun ZhangExecutive Director1.16M1979
Mr. Jiawei WeiDeputy GM & Executive Director1.68M1979
Mr. Han ZhangChief Financial Officer & Joint Company Secretary01987
Ms. Siu Ying KwokJoint Company Secretary01985

Description

Shanghai HeartCare Medical Technology Corporation Limited engages in the research, development, manufacture, and sale of neuro-interventional medical devices worldwide. The company offers ischemic stroke thrombectomy, intracranial stenosis treatment, ischemic stroke prevention, hemorrhagic stroke treatment, and vascular access devices. Its products are used for the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis, as well as for the treatment of hemorrhagic stroke. The company was formerly known as Shanghai Care Medical Technology Corporation Limited. Shanghai HeartCare Medical Technology Corporation Limited was incorporated in 2016 and is headquartered in Shanghai, the People's Republic of China.